Urology Flashcards

1
Q

What are the causative organisms of a UTI?

A

Most occur through the introduction of gut flora into the urethra. Usually caused by E. coli (80%). Other infectious agents include Proteus mirabilis, Klebsiella and Enterococci.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical features of a UTI?

A

Patients may be clinically asymptomatic.

Cystitis: Frequency, urgency, dysuria (pain on micturition), haematuria, suprapubic pain and smelly urine. On examination, patient may have suprapubic/abdominal/flank tenderness, or may have bladder distention.

Pyelonephritis: Fever, malaise, rigors, loin/flank pain. Patient may have fever or loin/flank tenderness. They may also have haematuria.

Prostatitis: Fever, lower back/perianal pain, and irritative and/or obstructive symptoms such as hesitancy, urgency, intermittency, poor stream and dribbling. On examination patient may have a tender, swollen prostate.

Elderly: Confusion, incontinence, nocturia and malaise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors for a UTI?

A
  • Sexually activity
  • Pregnancy
  • Incomplete bladder emptying
  • Urinary calculi
  • Diabetes mellitus
  • Structural abnormality of the urinary tract
  • Urinary catheterisation - UTI is the most common hospital acquired infection, the majority of which are associated with catheter use.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the useful investigations for a UTI?

A

When investigating a suspected uncomplicated UTI/pyelonephritis, helpful investigations include:

  • Urine dipstick: leucocytes + nitrites (product of coliform metabolism). If both negative a UTI is unlikely.
  • MSU for urine microscopy, culture and sensitivities.
    • If squamous epithelial cells present, this suggests urethral contamination, meaning that sample is from urethra not bladder and is therefore not a true MSU. This means it may not be representative of the bladder and is not very clinically relevant.
    • Under microscopy: The presence of white cells means pyuria, which is indicative of infection.
    • Culture:
      • Patients with infection usually have at least 10^5 cfu/mL (cfu = colony forming units) in urine in the bladder. However, the cut off is lower (10^4) for E. Coli, as that amount of growth would be indicative of UTI.
      • Patients without infection have sterile bladder urine and with proper collection, voided urine usually contains less than 10^4 cfu/mL.
  • Bloods – FBC, UE, CRP (inflammatory markers and renal function)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In which cases of suspected UTI is MC&S recommended?

A

Laboratory testing for culture and sensitivity should be performed in:

  • All pregnant women with bacteriuria, be it asymptomatic, or symptomatic and investigating a possible UTI.
  • Patients older than 65 years of age
  • Suspected UTI in children.
  • Suspected pyelonephritis (high temperature; rigours; nausea; vomiting; diarrhoea; loin pain or tenderness)
  • Suspected UTI in men
  • Catheterised patients with features of systemic infection.
  • Failed antibiotic treatment.
  • Community ESBLs
  • People with abnormalities of genitourinary tracts and renal impairment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In which cases of suspected UTI is imaging recommended?

A

When investing a complicated UTI, particularly if recurrent pyelonephritis or pyelonephritis in a male, it is important to perform a renal USS and/or intravenous urography to investigate underlying structural abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which cases of a suspected UTI should be referred to secondary care?

A

If the patient has haematuria: Re-test the patient after the course of antibiotics and refer through 2-week referral pathway if persistent and suspecting bladder or gynaecological malignancy.

For men with a UTI, consider referral to urology if:

  • Have ongoing symptoms despite appropriate antibiotic treatment.
  • May have an underlying cause or risk factor for the UTI (such as suspected bladder outlet obstruction, or have a history of pyelonephritis, urinary calculi, or previous genitourinary tract surgery).
  • Have recurrent episodes of UTI (for example, two or more episodes in a 6-month period).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the antibiotic therapy for a UTI

A
  • Most treatment will be empirical therapy as the treatment usually begins before culture and sensitivity results are received. Empirical therapy will be determined by local guidelines, which will take local resistance patterns into account.
  • Trimethoprim or Nitrofurantoin is used in the community to treat UTIs. Trimethoprim is becoming more and more redundant, as 40% of E.Coli is already resistant, so in secondary care, they are started on another antibiotic, usually Cefalexin or Nitrofurantoin.
  • For men with suspected prostatitis - prescribe a quinolone antibiotic such as Ciprofloxacin or Levofloxacin for 14 days.

Generally management guidelines state:

  • 3 day therapy with standard doses for uncomplicated lower urinary tract infection in women
  • 7 day therapy for:
    • Women with previous UTI caused by antibiotic resistant organisms
    • If at risk of upper UTI (pyelonephritis)
    • Men
  • 14 days for men if suspicion of prostatitis. Review after 14 days and prescribe a further 14 days if necessary. If chronic prostatitis then 4-6 weeks.

For pregnant or breastfeeding women:

  • 1st line = cefalexin 500mg BD PO for 7 days
  • 2nd line = co-amoxiclav 625mg TDS PO for 7 days (avoid nitrofurantoin as may produce neonatal haemolysis at term, but otherwise safe in pregnancy).
  • Anaphylactic penicillin allergy: discuss with ID/Micro
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the definition and epidemiology of Pyelonephrosis?

A

Pyelonephritis is an infection of the renal pelvis and parenchyma that is usually associated with an ascending bacterial infection of the bladder. It occurs more commonly in females and risk factors include pregnancy and urinary tract obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical features of Pyelonephritis?

A

Pyelonephritis typically manifests suddenly with signs and symptoms of both systemic inflammation and bladder infection (however, up to 20% do not have bladder symptoms).

  • High fever, chills
  • Flank pain, costovertebral angle tenderness (usually unilateral, may be bilateral)
  • Dysuria as well as other symptoms of cystitis (e.g., frequency, urgency)
  • Weakness, nausea, vomiting (diarrhoea may also be present)
  • Possible abdominal or pelvic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the diagnosis of pyelonephritis

A

In all people suspected of having acute pyelonephritis, arrange collection of a mid-steam urine (MSU) or catheter specimen of urine (CSU) for culture before starting empirical drug treatment. Presence of micro-organism is needed to confirm diagnosis of pyelonephritis.

Dipstick testing is not necessary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the investigations for Pyelonephrosis in secondary care?

A

Usually done in secondary care:

  • Urinalysis commonly shows blood, protein and nitrites. Pyuria is often present. Microscopy and culture should also be performed.
  • All patients should have U&Es to assess renal dysfunction, dehydration, and acute-on-chronic failure. Other important tests include FBC, glucose and blood cultures.

Abdominal X-Ray may show stones or soft-tissue mass on affected side. An USS should be used to exclude obstruction and delineate renal and perirenal collections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the primary care management of Pyelonephrosis

A

Admit people to hospital if symptoms or signs suggesting a more serious illness or condition (for example, sepsis).

Consider referral if:

  • Patients are male
  • Are significantly dehydrated or unable to take oral fluids and medicines.
  • Are pregnant.
  • Have a higher risk of developing complications — people with known or suspected structural or functional abnormality of the genitourinary tract or underlying disease (such as diabetes mellitus, or immunosuppression).
  • Have recurrent episodes of UTI (for example, two or more episodes in a 6-month period).

For women who are not pregnant, men, and people with indwelling catheters, take account of local antimicrobial resistance data, and prescribe either of the following first line options:

  • Cefalexin 500mg twice or three times a day (up to 1– 1.5g three or four times a day for severe infections) for 7-10 days.
  • Ciprofloxacin 500 mg twice a day for 7 days.
  • Co-amoxiclav (only if appropriate in line with culture and sensitivity results) 500/125 mg three times a day for 7-10 days.
  • Trimethoprim (only if appropriate in line with culture and sensitivity results) 200mg twice a day for 14 days.

For pregnant women who do not require admission, prescribe:

  • Cefalexin 500mg twice or three times a day (up to 1– 1.5g three or four times a day for severe infections) for 7-10 days.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the secondary care management of Pyelonephrosis

A
  • Take an A-E approach and stabilise the patient with I.V fluids. Maintain with a high level of fluid intake (e.g. 3L/24h). Monitor fluid balance and urine output carefully for the first 48-72h.
  • Give IV antibiotics
  • Organise drainage of infected and obstructed urinary system.
  • Analgesia: try opiates. Avoid NSAIDs in AKI.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the definition and epidemiology of nephrolithiasis?

A

Kidney stones (nephrolithiasis) refers to the presence of crystalline stones (calculi) within the urinary system.

It is quite common, with lifetime incidence up to 12%. Peak age at presentation is 20-50 years. Affects males more than females (2:1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of urinary calculi?

A

A history of nephrolithiasis is a strong risk factor (50% of patients will develop another kidney stone within 10 years). Depending on the size, it may be asymptomatic.

When stones cause pain, we can call this renal colic (though not entirely colicky). The pain tends to be severe and acute onset around the flank just over the kidneys. It then radiates to the groin and scrotum/labia when the stone lodges in the ureter, causing spasms - at this point, the pain is very severe, and gets worse in a colicky nature.

Patients can also have symptoms of dysuria, increased frequency, strangury (painful frequent urination with feeling of incomplete emptying) and penile tip pain. Patients may also complain of nausea and vomiting.

Haematuria is also a common feature. This can be macroscopic or microscopic (present in up to 90% of cases).

Occasionally, patients may also have signs and symptoms of a Urinary Tract Infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the investigations for urinary calculi?

A

Blood tests can show increased WCC (due to UTI) or hypercalcaemia (pointing towards hyperparathyroidism). A pregnancy test should be performed in all female patients. U&Es should be performed to measure kidney function.

Urinalysis may be positive for leukocytes, microscopic/macroscopic haematuria and nitrates. Microscopy and culturemay be indicated if infection is suspected.

A CTKUB non-contrast scan is the preferred imaging modality for nephrolithiasis due to its high sensitivity and specificity, and should be ordered as soon as nephrolithiasis is suspected.

A plain KUB (Kidney, Ureter, Bladder X-ray) shows radio-opaque stones. Up to 85% of stones are visible. An IVU (Intravenous Urogram) is a test where IV contrast followed by radiographs may show a filling defect.

A renal ultrasound can show calcification along the urinary tract as well as hydronephrosis. However stone needs to big to visualise.

Chemical analysis of the stone if passed shows what type of stone it is, and can help guide management.

18
Q

Describe the management of urinary calculi

A

All patients need to be hydrated well (orally or IV) and given analgesia including NSAIDs and opiates and offered anti-emetics.

Admit the patient if they have:

  • Single kidney
  • Pyrexia
  • Continuing pain
  • Renal impairment

If there is bacteriuria treat with antibiotics and surgical decompression (stent placement).

If the stone is small: do all the above and treat with alpha antagonist like tamsulosin to reduce spasms. This may also help stones pass spontaneously. Still recommended in the NICE guidelines, however controversial.

If the stone is big, or associated with infection it needs to be managed urologically: Extracorporeal shock wave lithotripsy (ESWL) is an un-invasive way to break up the stone, and is considered the first-line therapy. Second line is surgical removal through a cystoscope, from which a laser can be passed through. Uteroscopy is associated with better stone-free rates than EWL.

19
Q

What is the definition and epidemiology of Prostate cancer?

A

Prostate cancer refers to a malignant tumour of glandular origin (adenocarcinoma in 95% of cases), situated in the prostate. Prostate cancer is the second commonest cause of cancer mortality. It is very common - approximately 15% of men born today will be diagnosed with prostate cancer at some point in their lives. Less likely to affect Asians.

20
Q

What are the risk factors for Prostate cancer?

A
  • Age >50
  • Black ethnicity (increased prevalence as well as mortality risk) or European descent.
  • Family history of prostate cancer. 2-fold increased risk of prostate cancer in men with a FHx in a single first-degree relative, a 5-fold risk if there were 2 affected relatives, and a relative risk of 10.9 when there were 3 first-degree relatives with prostate cancer.
  • High levels of dietary fat.
21
Q

What are the clinical features of Prostate cancer?

A

The most common presenting finding is an elevated PSA level, beyond normal for their age.

Patients are usually asymptomatic as prostate cancer arises from the peripheral zone of the prostate. Symptoms similar to Benign Prostatic Hyperplasia are not very common in low-risk disease. If present, may be a sign of higher T-stage or BPH itself:

  • Nocturia
  • Urinary hesitancy
  • Urinary frequency
  • Dysuria (difficulty or painful urinating?)

On examination, a abnormal digital rectal examination is common (asymmetrical or nodular with loss of medial sulcus).

Signs of advanced metastatic disease include weight loss/anorexia, lethargy, bone pain and palpable lymph nodes.

22
Q

Describe the diagnosis of Prostate cancer

A

PSA is usually elevated

  • the cut-off is now age-adjusted:
  • 50-59 years >3.0 mg/l.
  • 60-69 years >4.0 mg/l.
  • > 70 years >5.0 mg/l.

PSA levels may also be raised by*:

  • Benign prostatic hyperplasia (BPH)
  • Prostatitis and urinary tract infection (NICE recommend to postpone the PSA test for at least 1 month after treatment)
  • Ejaculation (ideally not in the previous 48 hours)
  • Vigorous exercise (ideally not in the previous 48 hours)
  • urinary retention
  • instrumentation of the urinary tract

On rectal examination, the prostate may feel enlarged and ‘craggy’ or a hard nodule may be palpable.

Patients with a suspicious PSA test OR rectal examination should be referred using the 2 week pathway.

The traditional investigation for suspected prostate cancer was a transrectal ultrasound-guided (TRUS) biopsy. However, recent guidelines from NICE have now advocated the increasing use of multiparametric MRI as a first-line investigation. The results are reported using a 5-point Likert scale. If the Likert scale is >=3 a MRI-influence prostate biopsy is offered.

If a malignancy is diagnosed, the staging procedures involve a bone scan and pelvic CT/MRI scans (and extra-pelvic if further metastases are suspected).

23
Q

Describe the staging of Prostate cancer

A

Using the TNM system.

  • T1 = clinically apparent, but not visible (on imaging) nor palpable.
  • T2 = visible tumour
  • T3 (advanced) = tumour extents beyond the prostate capsule
  • T4 (advanced) = Tumour invades beyond seminal vesicles

N1 = metastases in regional lymph nodes

M1 = distant metastases (including non-regional lymph nodes).

24
Q

Describe the management of Prostate cancer

A

Localised prostate cancer (T1/T2)

Treatment depends on life expectancy and patient choice. Options include:

  • Conservative: active monitoring & watchful waiting
  • Radical prostatectomy
  • Radiotherapy: external beam and brachytherapy

Localised advanced prostate cancer (T3/T4)

Options include:

  • Hormonal therapy: see below
  • Radical prostatectomy: erectile dysfunction is a common complication
  • Radiotherapy: external beam and brachytherapy. Patients are at increased risk of bladder, colon, and rectal cancer following radiotherapy for prostate cancer.

Metastatic prostate cancer disease - hormonal therapy

  • Synthetic GnRH agonist e.g. Goserelin (Zoladex). Cover initially with anti-androgen to prevent rise in testosterone.
  • Anti-androgen such as cyproterone acetate prevents DHT binding from intracytoplasmic protein complexes.
  • Orchidectomy
25
Q

What is the definition and epidemiology of Urinary retention??

A

Urinary retention is the inability to voluntarily empty the bladder. Urinary retention can be acute or chronic.

  • Whilst acute urinary retention is common in men, it rarely occurs in women (incidence ratio of 13:1). It occurs most frequently in men over 60 years of age and incidence increases with age.
  • It has been estimated that around a third of men in their 80s will develop acute urinary retention over a five year period.
26
Q

What is the aetiology of Urinary retention??

A
27
Q

What are the clinical features of Urinary retention??

A

Patients present with inability to void. Bladder is distended and palpable.

  • Acute is always painful while chronic is painless.
  • Acute occurs suddenly, whereas chronic is gradual

Painless urinary retention: must exclude cauda equina syndrome. They may also have other signs such as:

  • Lower limb weakness
  • Saddle anaesthesia
28
Q

What are the investigations for Urinary retention??

A

All men and women should have a rectal and neurological examination to assess for the likely causes above. Women should also have a pelvic examination.

Investigations:

  • Patients should all be investigated with a urine sample which should be sent for urinalysis and culture. This might only be possible after urinary catheterisation.
  • Serum U&Es and creatinine should also be checked to assess for any kidney injury.
  • A FBC and CRP should also be performed to look for infection
  • PSA is not appropriate in acute urinary retention as it is typically elevated

To confirm the diagnosis of acute urinary retention a bladder ultrasound should be performed. A volume of >300 ccconfirms the diagnosis.

29
Q

Describe the management of Urinary retention

A

Acute urinary retention is managed by decompressing the bladder via catheterisation.

Further investigation should be targeted by the likely cause:

  • In reversible causes such as UTI, resolution with treatment is sufficient and further investigation is not necessary.
  • Men not diagnosed by BPH should be further evaluated by a urologist.
  • Patients with neurological symptoms should be evaluated by a neurologist and women with gynaecological symptoms by a gynaecologist.
  • Where no likely cause is identified, patients should be evaluated by a urologist for anatomical and urodynamic causes.
30
Q

What is the definition and epidemiology of Testicular Tortion?

A

Testicular Torsion is a urological emergency caused by the twisting of the testicle on the spermatic cord, leading to the constriction of the vascular supply to the testicle. This causes time-sensitive ischaemia and necrosis of testicular tissue.

Has a bimodal distribution: Extravaginal torsions affect neonates while intravaginal torsions affect adolescent boys (though can affect any age).

31
Q

What are the clinical features of Testicular Tortion?

A

Patients present with sudden-onset scrotal pain, often with nausea and vomiting. The pain is not relieved by elevation. With time, scrotal swelling and erythema develops, and so can hydrocele. Patients also commonly have abdominal pain.

The patient may have a history of intermittent testicular pain, suggestive of previous torsion and spontaneous de-torsion.

On Examination

The testicle is tender on palpation. The affected testicle may be described as a high-riding testicle as it can appear higher than unaffected testicle, or higher than usual.

There may be a horizontal lie on the affected testicle, and absent cremasteric reflex. No pain relief on elevation - unlike epididymitis.

##

32
Q

What are the investigations for Testicular Tortion?

A

Ultrasounds can visualise a testicular torsion. A Doppler ultrasound can also show decreased blood flow in the affected testicle.

FBC and urinalysis is normal

33
Q

Describe the management of Testicular Tortion

A

If torsion is suspected, seek a urological consult immediately as the testicle requires intervention within 6 hours. They will probably conduct an emergency scrotal exploration with emergency surgical fixation. They may conduct a orchidopexy (attaching testicle presently to the scrotum) or an orchiectomy (surgical removal).

Morphine sulphate is usually given to support patient with severe pain. Usually given with anti-emetics.

Manual de-torsion may be attempted if surgery is not available within 6-hours. This involves rotating the right testicle anti-clockwise or the left testicle clockwise (also called the open book method).

34
Q

What are the potential complications of Testicular Tortion?

A
  • If the testis remains twisted for more than 10 to 12 hours, ischaemia and irreversible testicle damage are likely. After 12 hours, necrosis most likely has occurred.
  • Infertility secondary to loss of testicle.
  • Psychological and cosmetic implications of losing a testis.
  • Recurrent torsions are likely, even with orchidopexy.
35
Q

What is the definition and epidemiology of Benign Prostatic Hyperplasia?

A

Benign Prostatic Hyperplasia is the benign enlargement of the prostate gland, leading to urinary symptoms. It is very common, and will affect every male if they live long enough.

  • Around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms.
  • Around 80% of 80-year-old men have evidence of BPH
  • Affects black> white > Asians tend to be less affected by BPH.
36
Q

What are the clinical features of Benign Prostatic Hyperplasia?

A

LUTS (Lower Urinary Tract Symptoms) can be split into storage and voiding symptoms:

Storage symptoms occur due to bladder irritation (can also be called irritative symptoms, and can occur in females with a UTI). These include:

  • Increased frequency in urination. Often first noticed by nocturia.
  • Urgency in urination.

Voiding/obstructive symptoms occur due to obstruction at the bladder neck usually because of prostatic enlargement(so can also be called obstructive symptoms). These include:

  • Hesitancy (difficulty initiating urination)
  • Weak-stream
  • Intermittency
  • Straining
  • Incomplete emptying
  • Post-voiding dribbling.

Uncommonly, the patient can also present with acute retention or UTIs.

37
Q

What are the potential complications of Benign Prostatic Hyperplasia?

A
  • Recurrent UTIs
  • Acute obstructive urinary retention
  • Bladder stones
  • Renal insufficiency, erectile dysfunction, overactive bladder.
38
Q

What are the investigations for Benign Prostatic Hyperplasia?

A
39
Q

Describe the management of Benign Prostatic Hyperplasia

A

Lifestyle measures such as reduce caffeine/tea intake. Bladder retraining, treat constipation, exercise.

Mild (0-7 IPSS)

Mild disease that does not bother the patient, is managed by watchful waiting.

If there is significant bother, treat with alpha blockers (smooth muscle relaxation in the prostate and bladder neck) such as tamsulosin and doxazosin (alpha blockers end in osin). Phosphodiesterase-5 (PDE-5) blockers such as sildenafil (Viagra) have been shown to improve symptoms, erectile dysfunction and quality of life.

NSAIDs such as celecoxib can improve flow.

Moderate and Severe

Treated as above, or with 5-alpha-reductase inhibitor (to reduce serum dihydrotestosterone) such as finasteride. If necessary, combine 5-alpha-reducase inhibitor with alpha blockers, PDE-5 blockers and NSAIDs.

If progressive, and cancer is suspected, surgery may be advised (Usually TURP). See here.

40
Q

What is the aetiology of Epididymo-orchitis?

A

Epididymo-orchitis describes an infection of the epididymis +/- testes resulting in pain and swelling. It is most commonly caused by local spread of infections from the genital tract (such as Chlamydia trachomatis and Neisseria gonorrhoeae) or the bladder.

Aetiology:

  • Sexually transmitted infections are the most common cause among young males (usually <35 years of age).
    • Chlamydia trachomatis and Neisseria gonorrhoea are the most common causes.
    • Others include Treponema pallidum, Trichomonas vaginalis, Gardnerella vaginalis.
  • Urinary tract infections are the cause among older males and children with E.coli being the most common cause.
41
Q

What are the clinical features of Epididymo-orchitis?

A

Presents as unilateral scrotal pain and swelling (though may be bilateral in 5-10% of cases). The pain may develop over several days and radiates to the ipsilateral flank. Urethral discharge may be present, but urethritis is often asymptomatic.

If the patient is older, or a child, for whom UTIs are the common cause they may also present with dysuria, urgency and frequency.

On examination:

  • The scrotal skin overlying the epididymis may appear red, shiny and oedematous.
  • Positive Prehn sign = reduced pain when hemiscrotum is elevated. This does not happen for testicular torsion, which is the most important differential which needs to be excluded urgently to prevent ischaemia of the testicle.

Other factors suggesting testicular torsion include patients < 20 years, severe pain and an acute onset.

42
Q

Describe the management of Epididymo-orchitis

A

The British Association for Sexual Health and HIV (BASHH) produced guidelines in 2010:

  • If the organism is unknown BASHH recommend: ceftriaxone 500mg intramuscularly single dose, plus doxycycline 100mg by mouth twice daily for 10-14 days.

Further investigations following treatment are recommended to exclude any underlying structural abnormalities.